Bergamot extracts have been shown in various human studies to elicit powerful health benefits. Studies demonstrate that the flavonoids found in bergamot have the ability to improve cholesterol ratios, reduce visceral fat, support liver function and positively affect insulin sensitivity.
Natroceutics Bergamot-HT harnesses the unique therapeutic potential of Italian bergamot and Spanish olive fruit. Bergamot produces a novel composition of guaiacyl and other citrus flavonoids. These have been standardised into an extract that mimics fresh whole bergamot juice and then potentised through the use of Phytosome™ delivery technology. Phytosome™ enhances the bioavailability of the citrus bioflavonoids which otherwise have poor oral absorption.
Each serving of Bergamot-HT delivers 10 mg of Hydroxytyrosol, which is the equivalent of an average serving of 30 ml of EVOO (Extra Virgin Olive Oil). These two compounds in their own right provide exceptional health benefits. When combined, they offer a potent and novel combination to support cardiovascular and metabolic health, demonstrating a direct and measurable ability to reduce visceral fat.
Serving Size: 1 Capsule | |
Bergamot Phytosome™ [providing Citrus x limon (L.) Osbeck (bergamot) 200 mg (fruit juice; 200:1 extract) with 250 mg phospholipids as sunflower lecithin (carrier)] |
500 mg |
Olea europaea L. (olive) [fruit; 250-300:1 extract standardised to yield 67% (10 mg) hydroxytyrosol (HT)] |
15 mg |
SERVING SIZE: 1 Tablet
NAPPI CODE: 3008668-001